South-Westphalia University of Applied Sciences, Interdisciplinary Center for Life Sciences, Iserloh, Germany.
J Biomed Opt. 2021 Mar;26(4). doi: 10.1117/1.JBO.26.4.043007.
Bioactive proteins represent the most important component class in biopharmaceutical products for therapeutic applications. Their production is most often biotechnologically realized by genetically engineered microorganisms. For the quality assurance of insulins as representatives of life-saving pharmaceuticals, analytical methods are required that allow more than total protein quantification in vials or batches. Chemical and physical factors such as unstable temperatures or shear rate exposure under storage can lead to misfolding, nucleation, and subsequent fibril forming of the insulins. The assumption is valid that these processes go parallel with a decrease in bioactivity.
Infrared (IR) spectroscopy has been successfully utilized for secondary structure analysis in cases of protein misfolding and fibril formation.
A reliable method for the quantification of the secondary structure changes has been developed using insulin dry-film Fourier-transform IR spectroscopy in combination with the attenuated total reflection (ATR) technique and subsequent data analyses such as band-shift determination, spectral band deconvolution, and principal component analysis.
A systematic study of insulin spectra was carried out on model insulin specimens, available either as original formulations or as hormones purified by ultrafiltration. Insulin specimens were stored at different temperatures, i.e., 0°C, 20°C, and 37°C, respectively, for up to three months. Weekly ATR-measurements allowed the monitoring of hormone secondary structure changes, which are supposed to be negatively correlated with insulin bioactivity.
It could be shown that IR-ATR spectroscopy offers a fast and reliable analytical method for the determination of secondary structural changes within insulin molecules, as available in pharmaceutical insulin formulations and therefore challenges internationally established measurement techniques for quality control regarding time, costs, and effort of analysis.
生物活性蛋白是治疗性生物制药产品中最重要的一类成分。它们的生产通常通过基因工程微生物生物技术来实现。为了确保胰岛素等救命药物的质量,需要有分析方法来检测小瓶或批次中的总蛋白含量以外的其他物质。化学和物理因素,如不稳定的温度或储存时的剪切速率暴露,可能导致胰岛素错误折叠、成核和随后形成纤维。可以假设这些过程与生物活性的降低是平行的。
红外(IR)光谱已成功用于分析蛋白质错误折叠和纤维形成过程中的二级结构。
使用胰岛素干膜傅里叶变换红外光谱结合衰减全反射(ATR)技术,以及随后的数据分析,如波段移动确定、光谱带解卷积和主成分分析,开发了一种可靠的方法来定量测定二级结构变化。
对模型胰岛素标本进行了系统的胰岛素光谱研究,这些标本既有原始配方,也有通过超滤纯化的激素。胰岛素标本分别在 0°C、20°C 和 37°C 下储存长达三个月。每周进行 ATR 测量可监测激素二级结构变化,这些变化被认为与胰岛素生物活性呈负相关。
结果表明,IR-ATR 光谱为确定药物胰岛素制剂中胰岛素分子的二级结构变化提供了一种快速可靠的分析方法,因此挑战了国际上用于质量控制的现有测量技术,在时间、成本和分析工作量方面具有优势。